Concepedia

Publication | Closed Access

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+ cells in patients with type 2 diabetes

DOI

34

Citations

13

References

2015

Year

Yoshimasa Aso, Teruo Jojima, Toshie Iijima, Kunihiro Suzuki, Tomoko Terasawa, M. Fukushima, Atsushi Momobayashi, Kenji Hara, Kohzo Takebayashi, Kikuo Kasai,
Endocrine

References

YearCitations

Page 1